title: Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: improvement in glycemic control and neurological function.
authors.forename: Lucimary C
authors.initials: LC
authors.lastname: Gurgel
authors.forename: Felipe
authors.initials: F
authors.lastname: Crispim
authors.forename: Maria Helena S
authors.initials: MH
authors.lastname: Noffs
authors.forename: Erich
authors.initials: E
authors.lastname: Belzunces
authors.forename: Marcio A
authors.initials: MA
authors.lastname: Rahal
authors.forename: Regina S
authors.initials: RS
authors.lastname: Moisés
mesh_terms: D000328:Adult; D017668:Age of Onset; D019943:Amino Acid Substitution; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006580:Genetic Carrier Screening; D006801:Humans; D007223:Infant; D008297:Male; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D000099161:Kcnj11 Channel
chemical_list: D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds; D000099161:Kcnj11 Channel